The Healthcare and Macro-Economic Impacts of Living with Endemic COVID – Listening to Fitch
Health Populi
JUNE 24, 2021
We also expect innovation to come out of pharma and biotech labs, and who will pay for new-new therapies? For Medicare Part B programs alone, the drug could consume one-half of the total $57 billion of medicines spending… as much as the U.S. spends on NASA.
270 
Let's personalize your content